Investors

Webcast ImageWebcast
Edge Therapeutics, Inc. at Jefferies 2016 London Healthcare Conference  (Replay)
November 17, 2016 at 8:00 a.m. UKT
Edge Therapeutics, Inc. at Jefferies 2016 London Healthcare Conference
Thursday, November 17, 2016 8:00 a.m. UKT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening conditions.

We believe EG-1962, our lead product candidate, can fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. Read More

Lastest News

November 2, 2016 - Edge Therapeutics to Present at Investor Conferences in November
Read More
November 1, 2016 - Edge Therapeutics Reports Third Quarter Financial Results
Read More
October 25, 2016 - Edge Therapeutics to Host Conference Call on November 1, 2016 to Discuss Third Quarter Financial Results
Read More

Upcoming Events

DateTitle
January 9, 2017
through
January 11, 2017
Edge 1x1 meetings at J.P. Morgan 35th Annual Healthcare Conference

Stock Information

EDGE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$11.44
Change (%) Stock is Down 0.07 (0.61%)
Volume8,639
Data as of December 2, 2016 4:00 p.m. ET
Refresh quote

IR Contact

Gregory Gin
Email: ir@edgetherapeutics.com

Data provided by Nasdaq. Minimum 15 minutes delayed.

Printer Friendly Version Print PageE-mail this page Email PageRSS RSS FeedsE-mail Alerts Email AlertsView contacts IR ContactsDownload Financial Tear Sheet Financial Tear Sheet